Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People diagnosed with a type of early-stage breast cancer called DCIS (ductal carcinoma in situ) who have been recommended to receive radiation therapy after their main treatment
Who may not be able to join:
- People who are receiving or have been recommended any systemic cancer treatment (such as chemotherapy, hormone therapy, or targeted therapy) (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Tanja Marinko, MD, PhD, Institute of Oncology Ljubljana
Phone: 0038615879505
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Adverse events of radiation therapy; Adverse events of radiation therapy; Adverse events of radiation therapy; Adverse events of radiation therapy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.